Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 4674 participants.
Also called NCT06319846
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 4,674 participants
- Sponsor
- Registry
-
NCT06319846
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Recruiting
Technical summary
Registry record NCT06319846. Randomized; quadruple masking; primary purpose prevention. Start 2024-07-11 (actual); primary completion 2025-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tirofiban for Patients With intraCranial Artery Stenosis and High-risk Acute Non-disabling Cerebrovascular Events(CHANCE-4)
- Condition
- Ischemic Stroke, Acute
- Condition
- TIA (transient ischemic attack)
- Condition
- Symptomatic Intracranial Artery Stenosis
- Intervention (Drug)
- Tirofiban
- Intervention (Drug)
- Placebo
- Lead sponsor
- Beijing Tiantan Hospital
Record details
- Record id
cardio:ct-nct06319846- Content hash
c3a2dcf90db26a59307072f9241529cbf8ff28d77abf8be6e2d5ee34a69483e6